As I have mentioned many times, I am a long that has tried to believe in Gerald but have been frustrated most of the time. I tried to believe him after the billion share vote. I too thought Rubenfeld's "we're there" regarding LymPro was the real deal. But as we got into February and March and April without any significant interest from Big Pharma....and no other catalysts capable of up listing us....possibly without a RS as Gerald had intimated.....I gave up on believing Gerald's guidance yet again!!
Your quotes of mine demonstrate my true long position....albeit frustrated.
I think by mid 2016 the MS revenue could be nice. Maybe Lympro revenue will start picking up. We'll have the Eltoprazine data (if they ever have the cash to start it), and we'll be well into a Phase 1 trial with MANF/Retinitis. So the stock price could start doing nicely by then. I don't think we'll get very much for the diagnostic division until then.
2015 will see more tap dancing by Gerald.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links